GSEA showed that a total of 18 pathways were significantly activated in high-risk group compared with low-risk group, such as extracellular matrix (ECM)-receptor interaction, PI3K-Akt signaling pathway, p53 signaling pathway and small cell lung cancer (Fig. 5A, Table S4). Here, AKT1 is linked to small cell lung carcinoma.